Counselors in Lomita, CA Accepting Medicare

7 Counselors found. Showing 1 - 7

Dr. Patricia Minnitti, PH.D., MFT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2075 Palos Verdes Dr N, Suite 218, Lomita, CA 90717 Phone: 310-890-1029    Fax: 310-265-1216

Ms. Jennifer Vallejo Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 24330 Narbonne Ave, Lomita, CA 90717 Phone: 310-534-1083

Erica Camello, LMFT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2081 Palos Verdes Dr N, Lomita, CA 90717 Phone: 424-251-7600

Ms. Vanessa Jaztmin Barriga, MA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2081 Palos Verdes Dr N, Lomita, CA 90717 Phone: 213-712-9391

Liliana Medina Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 24330 Narbonne Ave # 2, Lomita, CA 90717 Phone: 310-534-1083

Fabela Gonzalez Contreras Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 24330 Narbonne Ave Ste 2, Lomita, CA 90717 Phone: 310-534-1083

Jessica Williams, LCSW Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 2081 Palos Verdes Dr N, Lomita, CA 90717 Phone: 310-325-6542

News Archive

Are Latin America and the Caribbean ready to meet the health challenges of the coming senior boom?

Advances in medicine and public health have dramatically increased life expectancy in Latin America and the Caribbean.But is the region ready to meet the challenges of the coming "senior boom"?

Touching story of young man fighting Alzheimer's disease

In her new unwavering memoir, Jim's Journey: The Story of a Young Man with Early On-set Alzheimer's (published by Trafford Publishing), debut author Gretchen L Dausey reveals the touching story of her husband's battle against Alzheimer's disease and her unwavering support despite the inevitable degeneration of his mind and body.

Halozyme presents new data from Ultrafast Insulin development program at 70th ADA

Halozyme Therapeutics, Inc. today announced Phase 2 results demonstrating that the subcutaneous coinjection of rHuPH20 (recombinant human hyaluronidase, PH20) with lispro significantly improves postprandial hyperglycemia, reduces hypoglycemia, and accelerates the absorption of mealtime insulin in patients with type 2 diabetes.

Positive results from BioMimetic Therapeutics' Phase III trial comparing Augment Bone Graft to autograft

BioMimetic Therapeutics, Inc. today announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft ("Augment"), to autograft for use in hindfoot and ankle fusion surgery.

Scientists link human gene to risk of developing Mild Cognitive Impairment

Connecting a human gene to the risk of developing the Alzheimer's precondition known as Mild Cognitive Impairment has been somewhat of a holy grail for scientists, but a team led by researchers from Cornell University has ended the quest.

Read more Medical News

› Verified 7 days ago